Compare Agilent Technologies Inc (A) vs NIO Inc. (NIO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs NIO Inc. — how do they compare? Agilent Technologies Inc trades at $128.5 (market cap $37.04B), while NIO Inc. trades at $4.9 (market cap $12.57B). The key difference: Agilent Technologies Inc is far larger — about 2.9× NIO Inc.'s market cap, and Agilent Technologies Inc pays a 0.78% dividend while NIO Inc. pays none. Which is the better fit depends on your goals.
| A | NIO | |
|---|---|---|
Market Cap | $37.04B | $12.57B |
Sector | Health | Consumer Cyclical |
52-Week High | $157.20 | $7.89 |
52-Week Low | $110.24 | $3.48 |
Enterprise Value | $38.59B | $11.81B |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
NIO trades at $4.88, up 1.88% with bearish technical signals despite strong delivery growth. The company shows improving fundamentals with revenue reaching $87.49B in 2025 and narrowing losses, though negative profitability metrics persist. Recent June deliveries surged 62.9% year-over-year, supporting margin expansion expectations. Analyst sentiment remains mixed with 50% buy ratings amid ongoing cash burn concerns.
NIO presents a high-risk turnaround opportunity with accelerating delivery growth and improving margins, but substantial losses and negative cash flow require careful monitoring. The stock faces technical resistance near $5 while benefiting from EV sector momentum and premium positioning in China's competitive market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →
